Using Twitter as a Data Source for Studying Public Communication about Cardiovascular Health

Person-to-person communication is one of the most persuasive ways people deliver and receive information. Until recently, this communication was impossible to collect and study. Now, social media networks, such as Twitter, allow researchers to systematically witness public communication about health, including cardiovascular disease. Twitter is used by more than 300 million people who have generated several billion Tweets, yet little work has focused on the potential applications of these data for studying public attitudes and behaviors associated with cardiovascular health.

In a study published online by JAMA Cardiology, Raina M. Merchant, M.D., M.S.H.P., of the University of Pennsylvania, Philadelphia, and colleagues examined the volume and content of Tweets associated with cardiovascular disease as well as the characteristics of Twitter users.

For this study, the researchers used Twitter to access a random sample of Tweets associated with cardiovascular disease from July 2009 to February 2015. Tweets were characterized relative to estimated user demographics. A random subset of 2,500 Tweets was hand-coded for content and modifiers.

From an initial sample of 10 billion Tweets, the authors identified 4.9 million with terms associated with cardiovascular disease; 550,338 were in English and originated from a U.S. county. Diabetes and heart attack represented more than 200,000 Tweets each, while the topic of heart failure returned fewer than 10,000 Tweets. Users who Tweeted about cardiovascular disease were more likely to be older than the general population of Twitter users (average age, 28.7 vs 25.4 years) and less likely to be male (47.3 percent vs 48.8 percent). Most Tweets (2,338 of 2,500 [93.5 percent]) were associated with a health topic; common themes of Tweets included risk factors (42 percent), awareness (23 percent), and management (22 percent) of cardiovascular disease.

"This study has 3 main findings. First, we identified a large volume of U.S.-based Tweets about cardiovascular disease. Second, we were able to characterize the volume, content, style, and sender of these Tweets, demonstrating the ability to identify signal from noise. Third, we found that the data available on Twitter reflect real-time changes in discussion of a disease topic," the authors write.

"Twitter may be useful for studying public communication about cardiovascular disease. The use of Twitter for clinical research is still in its infancy. Its value and direct applications remain to be seen and warrant further exploration."

Sinnenberg L, DiSilvestro CL, Mancheno C, et al.
Twitter as a Potential Data Source for Cardiovascular Disease Research.
JAMA Cardiol. Published online September 28, 2016. doi:10.1001/jamacardio.2016.3029.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...